• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
patient education

Hydroxyurea for Sickle Cell Disease

key information

source: American Society of Hematology

year: N/A


Hydroxyurea is a medicine that doctors have used to treat people with sickle cell disease since the 1980s. The Food and Drug Administration (FDA) approved it for treating adults with sickle cell disease in 1998. In 2017, the FDA approved it to treat children with sickle cell disease. Hydroxyurea is also used to treat cancer. But doctors use a lower dose (amount) to treat sickle cell disease than to treat cancer.

How Can Hydroxyurea Help With Sickle Cell Disease?

Hydroxyurea reduces the problems that sickle cell disease causes. People with sickle cell disease who take hydroxyurea have fewer:

• Pain crises
• Episodes of acute chest syndrome
• Blood transfusions
• Hospital stays

read more

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.